Yves Boussougant
University of Paris
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yves Boussougant.
Critical Care Medicine | 2000
Philippe Markowicz; Jean-Damien Ricard; Didier Dreyfuss; Laurence Mier; Patrick Brun; François Coste; Yves Boussougant; Kamel Djedaini
Objective: To determine whether three hydrophobic and hygroscopic heat and moisture exchangers (HMEs) retain their heating and humidifying properties (assessed by psychrometric measurements of absolute humidity, relative humidity, and tracheal temperature) for 48 hrs without any drop in their bacteriologic efficiency. Design: Prospective randomized clinical trial. Patients: Sixty‐one consecutive unselected mechanically ventilated intensive care unit patients. Interventions: Patients were randomly allocated to one of the three HMEs studied (Hygrobac‐Dar from Mallinckrodt, n = 21; Humid‐Vent from Gibeck, n = 20; and Clear‐Thermal from Intersurgical, n = 20). Measurements and Main Results: Hygrometric parameters were measured by psychrometry after 3, 24, and 48 hrs of use. Peak airway pressure was recorded every 6 hrs and averaged over 24 hrs. Bacterial colonization of both patients and circuits was studied. Patients in all three groups were similar in terms of age, indications for, and overall duration of mechanical ventilation. Tracheal tube occlusion never occurred. Hygrometric data included 371 measurements whereas bacteriologic data included >700 samples and cultures. The Hygrobac‐Dar HMEs gave a significantly higher absolute humidity whatever the time of measurement (3, 24, or 48 hrs) than the other two HMEs (p < .001). The Clear‐Thermal HMEs gave the poorest hygrometric parameters (p < .01); five of them were replaced prematurely (24 hrs) because the absolute humidity was <25 mg H2O/L. This did not occur for the other HMEs. Mean peak airway pressures were identical in the three groups. The bacterial colonizations of both patient and circuit were similar (and negligible for circuits) for all three groups. Conclusion: Some HMEs may be used safely for 48 hrs without change. However, this does not pertain to every brand of HME. Objective in vivo evaluation of their humidifying performances is decisive before extending their duration of use.
European Journal of Clinical Microbiology & Infectious Diseases | 1989
P. Weber; Yves Boussougant; R. Farinotti; C. Carbon
The activity of ofloxacin and cefotaxime, alone or combined, against four strains ofEnterobacteriaceae was evaluated both in vitro and in sera from volunteers given a single infusion over 30 min of 200 mg ofloxacin or 1 g cefotaxime. The strains showed resistance or decreased susceptibility to third-generation cephalosporins. The combination was not found to be synergistic in vitro. Analysis of the bactericidal titres and killing kinetics of sera taken at the time of the peak concentration and 6 h after the infusion, respectively, confirmed the absence of synergy between the drugs against these strains.
The American review of respiratory disease | 1991
Didier Dreyfuss; Kamel Djedaini; Philippe Weber; Patrick Brun; Jean-Jacques Lanore; Jamil Rahmani; Yves Boussougant; François Coste
American Journal of Respiratory and Critical Care Medicine | 1995
Didier Dreyfuss; Kamel Djedaini; Isabelle Gros; Laurence Mier; Geneviève Le Bourdellès; Yves Cohen; Philippe Estagnasie; François Coste; Yves Boussougant
JAMA Internal Medicine | 1996
Frédéric Barbut; Gérard Corthier; Yves Charpak; Marc Cerf; Henri Monteil; Thierry Fosse; André Trévoux; Bertille De Barbeyrac; Yves Boussougant; Sylvestre Tigaud; Francis Tytgat; Alain Sédallian; Suzanne Duborgel; Anne Collignon; Marie-Emmanuelle Le Guern; Paul Bernasconi; Jean-Claude Petit
American Journal of Respiratory and Critical Care Medicine | 1995
Kamel Djedaini; M Billiard; Laurence Mier; G Le Bourdelles; Patrick Brun; P Markowicz; Philippe Estagnasie; François Coste; Yves Boussougant; Didier Dreyfuss
The American review of respiratory disease | 1993
Catherine Pierre; Catherine Olivier; Denise Lecossier; Yves Boussougant; Patrick Yeni; Allan J. Hance
The American review of respiratory disease | 1993
Didier Dreyfuss; Laurence Mier; Geneviève Le Bourdellès; Kamel Djedaini; Patrick Brun; Yves Boussougant; François Coste
Archive | 1996
Frédéric Barbut; Gérard Corthier; Yves Charpak; Marc Cerf; H. Monteil; Thierry Fosse; André Trévoux; Bertille De Barbeyrac; Yves Boussougant; Sylvestre Tigaud; Francis Tytgat; Alain Sédallian; Suzanne Duborgel; Anne Collignon; Marie-Emmanuelle Le Guern; Paul Bernasconi; Jean-Claude Petit
The Journal of Infectious Diseases | 1987
Claude Carbon; Philippe Weber; Marc Lévy; Yves Boussougant; Marc Cerf